Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) ␣ and ␤ were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17␤-estradiol (E 2 ; 10 Ϫ8 -10 Ϫ6 M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E 2 was attenuated with tamoxifen treatment (10 Ϫ6 M), the estrogen antagonist, suggesting that the effect of E 2 is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E 2 treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E 2 effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10 Ϫ6 M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E 2 (10 Ϫ8 -10 Ϫ6 M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E 2 resulted in a significant increase of bcl-2 mRNA and protein levels (2-and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E 2 may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ER␣ and ER␤ at the mRNA and protein levels. In addition, E 2 prevented tamoxifen induced-apoptosis through ERs. The mechanism of E 2 action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells. (Endocrinology 142: [2351][2352][2353][2354][2355][2356][2357][2358][2359][2360] 2001) 
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The common epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE), which is a simple squamous-to-cuboidal mesothelium covering the ovary (18) . The exact mechanism of ovarian tumorigenesis is not well known even though this disease is the most frequent cause of cancer death in gynecological malignancies (19) . Repeated ovulation contributes to neoplastic transformation of OSE, indicating that the process of healing ruptured OSE may contribute to the disease (19, 20) . Therefore, it has been suggested that endocrine and autocrine factors may influence the occurrence of ovarian tumors in women (19 -24) . Actions of estrogen are mediated through an interaction with its intracellular receptor, a member of the steroid/thyroid/retinoid receptor gene superfamily (reviewed in Ref. 25) . The classical estrogen receptor (ER, now referred to as ER␣) was thought to be the only form of nuclear receptor able to bind estrogen, and mediate its hormonal effects in their target tissues. However, the cloning of a second form of ER, now referred to as ER␤, has caused a reexamination of the estrogen signaling system (26) . Recent studies have revealed different tissue distributions and expression levels of ER␣ and ER␤ in the ovary, suggesting different biological roles of ER␣ and ER␤ in this tissue (26 -28) . In addition, the existence of ER␣ and ER␤ in normal OSE and ovarian cancers has been demonstrated (29, 30) . Although 17␤-estradiol (E 2 ) is not a mitogen for normal OSE (31), treatments with exogenous estrogen resulted in a growth stimulation of several ERpositive ovarian carcinoma cell lines in vitro (32) (33) (34) . However, the role of estrogen in ovarian tumorigenesis and regulation of apoptosis by estrogen in neoplastic OSE cells remains uncertain.
The present study was performed to investigate the role of E 2 in the regulation of apoptosis in normal, early neoplastic, tumorigenic, and late neoplastic OSE cells. Recently, nontumorigenic [immortalized OSE (IOSE) -29] and tumorigenic (IOSE-29EC) immortalized OSE cells were generated from normal OSE directly by transfection with simian virus 40-large T antigen and subsequent E-cadherin (35, 36) . These IOSE-29EC cells were found to be anchorage independent and formed transplantable, invasive sc and ip adenocarcinomas in SCID mice (37) . Two additional cell lines, designated IOSE-29EC/T4 and IOSE-29EC/T5, were established from tumors that arose in IOSE-29EC-inoculated SCID mice (37) . The characteristics of these cell lines resemble those of ovarian cancer (36, 37) . The expression of ER␣ and ER␤ was determined in these OSE cell lines to investigate the effect of E 2 . Furthermore, cell proliferation and prevention of apoptosis by E 2 were examined in these generated immortalized OSE cell lines. Finally, to elucidate the mechanism of E 2 in the prevention of apoptosis, the regulation of proapoptotic bax and antiapoptotic bcl-2 was investigated following treatments with E 2 and/or antiestrogen, tamoxifen.
Materials and Methods

Cell culture and treatments
Normal human OSE cells were scraped from the ovarian surface during laparoscopies for nonmalignant disorders and cultured as previously described (38) in medium 199:MCDB 105 (Life Technologies, Inc., Burlington, Canada; and Sigma-Aldrich Corp., Oakville, Canada, respectively) containing 10% FBS, 100 U/ml penicillin G, and 100 g/ml streptomycin (Life Technologies, Inc.) in a humidified atmosphere of 5% CO 2 -95% air and passaged with 0.06% trypsin (1:250)/0.01% EDTA in Mg 2ϩ /Ca 2ϩ -free HBSS when confluent. As outlined in Table 1 , we recently developed a culture system with cells representing several stages in the neoplastic progression of OSE. The IOSE-29 cell line (referred to as IOSE-Mar in some previous publications) was generated by transfection with the immortalizing simian virus 40 early genes into normal human OSE at passage 5 (35) . The IOSE-29EC cell line was made from IOSE-29 at passage 11 by transfecting the full-length mouse E-cadherin complementary DNA (cDNA) under the control of the ␤-actin promoter (36) . The IOSE-29EC/T4 and IOSE-29EC/T5 were established from tumors that arose in IOSE-29EC-inoculated SCID mice, and they formed tumors on mesenteries and omentum, invaded the liver and thigh musculature, and produced ascites (37 
RNA extraction and RT-PCR procedure
Total RNA was prepared from cultured cells using the RNaid kit (Bio/Can Scientific, Mississauga, Canada) according to the manufacturer's suggested procedure. RNA integrity was confirmed by agarose gel electrophoresis and ethidium bromide staining. The total RNA concentration was determined from spectrophotometric analysis at A 260/280 . cDNA was synthesized from 2.5 g total RNA by RT at 37 C for 2 h using a first strand cDNA synthesis kit (Pharmacia Ltd., Uppsala, Sweden). 
Southern blot analysis
Following electrophoresis, PCR products were transferred to nylon membranes (Hybond-N; Amersham Pharmacia Biotech) and fixed by UV irradiation. The blotted membranes were prehybridized for 3 h at 42 C in prehybridization solution containing 50% formamide, 5ϫ SSC, 0.1% N-lauroyl sarcosine, 0.02% SDS, and 2% blocking solution. The prehybridized membranes were hybridized overnight at 42 C with digoxigenine (DIG)-labeled probes. PCR products of ER␣ and ER␤ isolated from human granulosa cells were cloned into pCRII vector using the TA Cloning Kit (Invitrogen, San Diego, CA) and were sequenced by the dideoxy nucleotide chain termination method using the T7 DNA polymerase sequencing kit (Amersham Pharmacia Biotech.). The cDNA clones for bax and bcl-2 were subcloned from ovarian cancer cell line (OVCAR-3) and verified by sequence analysis already mentioned. The cDNA probes for ERs (␣ and ␤) and apoptotic genes (bax and bcl-2) were labeled with DIG cDNA labeling kit (Roche Molecular Biochemicals, Laval, Canada) for hybridization. The hybridized membranes were detected with luminescence method (Roche Molecular Biochemicals) and exposed to x-ray film for 1-10 min at room temperature. The specific bands were scanned and quantified using a computerized visual light densitometer (model 620; Bio-Rad Laboratories, Inc., Richmond, CA).
Immunoblot analysis
Immortalized OSE cell lines (IOSE-29, IOSE-29EC, IOSE-29EC/T4, and IOSE-29EC/T5) were seeded at a density of 2 ϫ 10 5 cells in 35-mm culture dishes and cultured in a humidified atmosphere of 5% CO 2 -95% air at 37 C. Cells were washed twice with ice-cold PBS and lysed in ice-cold RIPA buffer (150 mm NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50 mm Tris (pH, 7.5), 1 mm phenylmethylsulfonylfluoride, 10 g/ml leupeptin, and 100 g/ml aproteinin). The extracts were placed on ice for 15 min and centrifuged to remove cellular debris. Protein concentrations in the supernatants were determined using a Bradford assay (Bio-Rad Laboratories, Inc.). Thirty micrograms of total protein were run on 10% SDS-PAGE gels and electrotransferred to a nitrocellulose membrane (Hybond-C; Amersham Pharmacia Biotech). The membrane was immunoblotted using a mouse monoclonal antibody for ER␣ (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and a goat polyclonal antibody for ER␤ (Santa Cruz Biotechnology, Inc.). To determine whether the in vitro treatments affected the expression of the genes involved in apoptosis, the membranes were immunoblotted using mouse monoclonal antibodies of bax (BD PharMingen Inc., Mississauga, Ontario, Canada) and bcl-2 (Santa Cruz Biotechnology, Inc.). The loaded amount of protein was normalized with actin protein in the same membrane. After washing, the signals were detected with horseradish peroxidase-conjugated secondary antibody, and visualized using the enhanced chemiluminescence system (Amersham Pharmacia Biotech). 4 cells/well in 0.5 ml medium 199:MCDB105 supplemented with 10% FBS and antibiotics, and incubated for 48 h. On the day of treatment, the cells were incubated with increasing concentrations (10 Ϫ8 , 10 Ϫ7 , or 10 Ϫ6 m) of E 2 in phenol-red-free medium 199 with charcoal/dextran-treated FBS for 2-6 days. On the days indicated in the results, during the last 6 h of the incubations to be harvested, the medium was changed to include the same concentration of E 2 and 1 Biotech). At the end of the incubation period, the culture medium was removed and the cells were washed three times with PBS, followed by precipitation with 0.5 ml 10% trichloroacetic acid for 20 min at 4 C. The precipitate was washed in methanol twice and solubilized in 0.5 ml 0.1 n sodium hydroxide, and the incorporated radioactivity was measured in a 1217 Rackbeta liquid scintillation counter (LKB Wallac, Inc., Turku, Finland).
[ 3 H]Thymidine incorporation assay
DNA fluorometric assay
In addition to the [ 3 H]thymidine incorporation assay, the effect of E 2 on the growth of IOSE-29 and IOSE-29EC was determined by measuring the DNA content as previously described with some modifications in 24-well plates (42) . The cells were treated with various concentrations (10 Ϫ8 , 10
Ϫ7
, or 10 Ϫ6 m) of E 2 and/or tamoxifen (10 Ϫ6 m) in phenol-redfree medium 199 with charcoal/dextran-treated FBS for 6 days. After treatment, the cells were washed with TNE buffer (10 mm Tris, 1 mm EDTA, 2 m NaCl, pH 7.4) three times and stored at Ϫ70 C. On the day of assay, 250 l distilled water was added in the wells and incubated for 1 h at room temperature. The plates were frozen then for 1 h at Ϫ70 C and thawed until reaching room temperature. The amount of DNA was measured using an automated microplate fluorescence reader (Model FL600; Bio-Tek Instruments, Inc., Winooski, VA) at excitation wavelength 350 nm and emission wavelength 460 nm (sensitivity ϭ 90). The amount of DNA in the culture was calculated from inserting the fluorescence unit into a standard curve.
Quantification of apoptotic cells
To quantify the induction of apoptosis, DNA fragmentation was measured using the cell death detection enzyme-linked immunosorbent assay (ELISA; Roche Molecular Biochemicals) as previously described (4) . Briefly, the cells (1 ϫ 10 4 ) were plated in each well of 24-well plates. After treatments with E 2 and tamoxifen for 6 days, the used media were collected and stored during the treatments. The cells were washed with PBS, and 0.1 ml lysis buffer was added. Following a 15-min incubation on ice, apoptotic cells in cell lysates and used medium were assayed for DNA fragments according to the manufacturer's protocol. The same amount (1 g) of cell lysate was used for the procedure of cell death ELISA. DNA fragmentation was measured at 405 nm against untreated control.
Statistical analysis
Data are shown as the means of two or three individual experiments with triplicate samples, and are presented as the mean Ϯ sd. In the 
Results
Expression of ER␣ and ER␤ mRNAs
The mRNA levels of ER␣ and ER␤ in IOSE-29 (passages 13-16), IOSE-29EC (passages 15-17), IOSE-29EC/T4, and IOSE-29EC/T5 were investigated by RT-PCR and Southern blot analysis. The possibility of cross-contamination was ruled out because no PCR products were observed and detected in the negative control [TmA(Ϫ); without template in the room temperature reaction] by ethidium bromide (data not shown) and Southern blot analysis (Fig. 1) . A linear relationship between PCR products and amplification cycles was obtained in all cell types (data not shown). Predicted PCR products of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ER␣, and ER␤ were obtained as 373 bp, 540 bp, and 279 bp, respectively, and confirmed by Southern blot analysis using DIG-labeled probes (Fig. 1) and sequence analysis (data not shown). This result indicates that the mRNAs of ER␣ and ER␤ are expressed in IOSE-29, IOSE-29EC, IOSE-29EC/T4, and IOSE-29EC/T5.
Expression of ER␣ and ER␤ proteins
To investigate the expression of ER␣ and ER␤ proteins in immortalized OSE cell lines, immunoblot analysis was performed using the mouse monoclonal antibody for ER␣ and a goat polyclonal antibody for ER␤. As shown in Fig. 2 
Effects of E 2 on cell proliferation
To evaluate the role of E 2 in normal and immortalized OSE cell lines, the cells were treated with increasing concentrations (10
Ϫ8
, 10
Ϫ7
, and 10 Ϫ6 m) of E 2 for 2-6 days. The [ 3 H]thymidine incorporation and DNA fluorometric assays were performed as previously described in Materials and Methods. Tamoxifen (10 Ϫ6 m), which is an estrogen antagonist, was used to block the action of E 2 in the cell proliferation study. Treatment with E 2 did not affect the growth of normal OSE (Fig. 3A) , whereas E 2 treatment for 2-6 days resulted in an increase of the growth in OVCAR-3 cells in a time-dependent manner as positive control (Fig. 3B) . Highest proliferative effect of E 2 was observed at 10 Ϫ7 m, whereas the effect of E 2 was less increased at 10 Ϫ6 m in OVCAR-3 cells (Fig. 3B) . No difference was observed following E 2 treatment for 6 days in IOSE-29 cells by thymidine incorporation (Fig. 3C ) and fluorometric assay (Fig. 3D) . In contrast, treatment with E 2 (10
Ϫ8
-10
Ϫ6 m) before day 6 had no effect on thymidine incorporation, but it resulted in a significant increase on day 6 ( Fig. 3F; 3E ) and IOSE-29EC cells (Fig. 3H ), suggesting that E 2 effect does not include stimulation of proliferation. Treatment with tamoxifen only also caused inhibitory effect in IOSE-29 (Fig.  3 , C and D) and IOSE-29EC cells (Fig. 3, F and G) . In addition, a significant increase of thymidine incorporation by E 2 (10 Ϫ7 m) was also observed in IOSE-29EC/T4 and IOSE-29EC/T5 cells, whereas cotreatment with tamoxifen attenuated the E 2 effect (Fig. 3, I and J).
Effects of E 2 on apoptosis
To examine the role of E 2 in the prevention of apoptosis, DNA fragmentation was measured using the cell death detection ELISA. To quantify the induction of apoptosis, IOSE-29EC cells were treated with tamoxifen (10 Ϫ6 m) and/or E 2 (10
Ϫ8
, 10 Ϫ7 , and 10 Ϫ6 m) for 6 days. As shown in Fig 4 , treatment with tamoxifen resulted in a significant increase of DNA fragmentation in IOSE-29EC cells (100.0 Ϯ 5.89% vs. 287.7 Ϯ 11.26%). Cotreatments with E 2 (10 Ϫ8 , 10 Ϫ7 , and 10 Ϫ6 m) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner (Fig. 4 , and 287.7 Ϯ 11.26% vs. 219.8 Ϯ 21.47%, 175.8 Ϯ 12.02%, or 174.9 Ϯ 16.50%).
Expression of proapoptotic and antiapoptotic gene mRNAs and proteins
The mRNA levels of proapoptotic bax and antiapoptotic bcl-2 in IOSE-29 and IOSE-29EC were investigated by RT-PCR and Southern blot analysis. Predicted PCR products of GAPDH, bax, and bcl-2 were obtained as 373 bp, 323 bp, and 459 bp, respectively, and confirmed by Southern blot analysis using DIG-labeled probes (Fig. 5 ) and sequence analysis (data not shown). No difference was observed in the expression level of bax mRNA between IOSE-29 and IOSE-29EC cells. In contrast, the mRNA expression level of bcl-2 was higher in IOSE-29EC cells than IOSE-29 cells (Fig. 5A ). In parallel of mRNA level, protein level of bcl-2 was investigated in these cell lines. As shown in Fig. 5B , the expression level of bcl-2 protein was higher in IOSE-29EC cells than IOSE-29 cells.
Effect of E 2 on proapoptotic and antiapoptotic mRNAs
To investigate the mechanism of E 2 action in the prevention of apoptosis, the regulation of bax and bcl-2 was examined using RT-PCR in IOSE-29EC cells. The cells were treated with E 2 and/or tamoxifen for 24 h. The expected sizes of PCR products for bax and bcl-2 were obtained as 323 bp and 459 bp, respectively. The mRNA expression of bax and bcl-2 was normalized with GAPDH (373 bp) to quantify the mRNA levels. Treatments with E 2 (10 Ϫ8 -10 Ϫ6 m) up-regulated bcl-2 mRNA up to 2-fold in these cells (Fig. 6, A and B (Fig. 6A) .
Effect of E 2 on proapoptotic and antiapoptotic proteins
To investigate the protein levels of bax and bcl-2 by E 2 , immunoblot analysis was performed following E 2 and/or tamoxifen treatments. The cells were treated with E 2 and/or tamoxifen for 48 h as previously described in 
Materials and Methods.
Specific signals for bax and bcl-2 protein were detected at 21 and 26 kDa, respectively, as shown in Fig. 7 . Consistent with the mRNA levels, treatments with E 2 (10 Ϫ8 -10 Ϫ6 m) significantly up-regulated bcl-2 protein level in these cells (Fig. 7, A and B ; 100.0 Ϯ 9.92% vs. 162.05 Ϯ 12.68%, 166.7 Ϯ 19.61%, or 154.4 Ϯ 20.86%). Cotreatment with tamoxifen (10 Ϫ6 m) plus E 2 attenuated this E 2 effect (166.7 Ϯ 19.61% vs. 109.9 Ϯ 10.22%). In contrast, no significant difference in the protein level of bax was observed by E 2 treatment in IOSE-29EC cells (Fig. 7A) .
Discussion
The characteristics of IOSE-29EC resemble to those of ovarian cancer (35) (36) (37) . The previous reports have suggested that the IOSE-29 derived cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) transformation stages of human normal OSE. Thus, these cell lines should be a useful in vitro model to understand ovarian tumorigenesis because these cell lines were generated by introducing only two genes (simian virus 40 large T antigen and E-cadherin genes) into FIG. 6. Effect of E 2 on bax and bcl-2 mRNA levels. To investigate the mechanism of E 2 in the prevention of apoptosis, the regulation of bax and bcl-2 was examined using RT-PCR in IOSE-29EC cells. The cells were treated with E 2 and/or tamoxifen (Txf) for 24 h. The expected sizes of PCR products for bax and bcl-2 were obtained as 323 bp and 459 bp, respectively. The mRNA expression of bax and bcl-2 was normalized with GAPDH (373 bp) to quantify the mRNA levels. A, The expression of bax and bcl-2 mRNA after treatment with E 2 and/or tamoxifen. B, Relative bcl-2 mRNA expression after treatment E 2 and/or tamoxifen. Data are shown as the means of three individual experiments, and are presented as the mean Ϯ SD. a, P Ͻ 0.05 vs. untreated control; b, P Ͻ 0.05 vs. E 2 (10 Ϫ7 M) treatment. -30a ). In addition, the expression levels of ER␣ were enhanced when compared with those in normal ovaries, whereas ER␤ levels were significantly decreased in ovarian tumors, suggesting that ER␣ and ER␤ mRNAs are differentially expressed in normal and neoplastic OSE cells (30, 43) . These results suggest that overexpression of ER␣ relative to ER␤ mRNA may be a marker of ovarian tumorigenesis. Consistent with mRNA levels, ER protein is also highly expressed in ovarian carcinomas when compared with normal or benign ovarian tumors (44) . The open reading frame predicted from the ER␤ cDNAs encodes a protein of molecular mass of approximately 54 kDa, which contrasts with the size of ER␣ (approximately 67 kDa) detected by Western blotting (27, 39) . ER␣ and ER␤ can homodimerize (␣␣ or ␤␤) or heterodimerize (␣␤) upon binding to the ERE (45) . Thus, it is hypothesized that differential expression of ER␣ and ER␤ in ovarian tumors may alter a responsiveness of estrogen or antiestrogen treatment. Recently, a mutation involving a 32-bp deletion in exon 1 of ER␣ transcripts was detected in SKOV-3 cell line, which is not responsive to estrogen treatment even though this cell line is ER-positive (29) . In addition to its well-documented role in reproductive organs, it has been suggested that estrogen, especially E 2 , may be associated with ovarian tumorigenesis. Treatments with exogenous E 2 resulted in a growth stimulation of several ER-positive ovarian carcinoma cell lines in vitro (32) (33) (34) . Some cultures of human epithelial ovarian cancer cells have been demonstrated to produce E 2 and progesterone (46) . The present studies demonstrated that exogenous E 2 (10 Ϫ8 -10 Ϫ6 m) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells but not in IOSE-29. The effect of E 2 was attenuated by the estrogen antagonist tamoxifen (10 Ϫ6 m). This observation suggests that the effect of E 2 is mediated through specific receptors. Because there was no stimulatory effect on thymidine incorporation before day 6, and because the ratio of thymidine incorporation to DNA content per culture did not change, the E 2 effect does not include stimulation of proliferation. The growth of ERpositive ovarian tumors that are responsive to E 2 is also attenuated by antiestrogen, such as tamoxifen and the pure antiestrogen ICI 164,384 (47, 48) . It is not known yet which ERs (␣, ␤, or both) are blocked by tamoxifen treatment.
In the present study, E 2 does not appear to be mitogenic for IOSE-29EC cells even though E 2 resulted in a significant increase of thymidine after 6-day treatment, because the increase in thymidine incorporation was paralleled by an increase of DNA content per culture. In addition, no difference in proliferative index was obtained after E 2 treatment for 1 or 2 days (data not shown). These observations suggest that the increase in thymidine incorporation and DNA content may be due to reduced apoptosis. This increase in thymidine incorporation could reflect the stimulation of proliferation by E 2 (i.e. an increase in the proportion of dividing cells per total cell number), or it could be the result of an unchanged rate of proliferation in cell populations that had increased in size because apoptosis was inhibited. The observation that a significant increase in thymidine incorporation was only observed on day 6 of E 2 treatment supports the latter possibility. To define the basis for the increase in thymidine incorporation more definitely, we carried out total DNA determinations on the cell populations. These determinations showed an increase in DNA content that paralleled the changes in thymidine incorporation, i.e. the ratio of thymidine incorporation over total cell number did not change. Therefore, it appears that the increase in cell number on day 6 was the result of inhibited apoptosis rather than enhanced proliferation. Further, in the work presented here, treatment with tamoxifen (10 Ϫ6 m) only resulted in a growth-inhibitory effect in both IOSE- 29 ER-negative ovarian cancer cell line, A2780, and induce apoptosis (49), This estrogen-independent role of tamoxifen in ER-negative ovarian and breast cancer cells was well documented in previous studies (49 -51) , suggesting that tamoxifen (10 Ϫ6 m) may have dual functions, prevention of estrogen effect by blocking ER and inhibition of growth by itself through estrogen-independent manner in this experiment. Our results confirm others (31), which indicated that E 2 does not affect the growth of normal OSE. The role of ERs in OSE and IOSE-29 remains to be elucidated, but our results suggest that the introduction of E-cadherin resulted in altered ERelicited effect and responsiveness to E 2 or tamoxifen resembling that of ovarian cancer lines.
Dysregulation of proliferation and/or cell death plays a critical role in tumorigenesis. The present study demonstrates that tamoxifen (10 Ϫ6 m) can induce apoptosis in IOSE-29EC cells, whereas E 2 can attenuate the effect of tamoxifen on these cells. Only IOSE-29EC cells were further used for apoptosis study because this cell line expressed both ERs and responded to E 2 /tamoxifen treatments. Cotreatment with E 2 (10
Ϫ8
-10
Ϫ6 m) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Among proapoptotic and antiapoptotic genes in the bcl-2 family, bax and bcl-2 genes are dominant regulators for apoptosis. The ratio of bcl-2 to bax is important in determining susceptibility to apoptosis (52) . The present study has demonstrated that bax and bcl-2 are expressed at both mRNA and protein levels in neoplastic OSE cells. No difference was observed in the expression level of bax mRNA between IOSE-29 and IOSE-29EC cells. Interestingly, the expression level of bcl-2 mRNA and protein is higher in IOSE-29EC cells than IOSE-29 cells, suggesting that IOSE-29EC cells may be more resistant to apoptosis. In addition, treatments with E 2 resulted in a significant increase of bcl-2 mRNA level (up to 2-fold), whereas E 2 was attenuated with tamoxifen treatment, suggesting that the up-regulation of bcl-2 mRNA by E 2 is mediated through specific receptors, ERs. These findings are in agreement with a previous report where estrogen up-regulated antiapoptotic bcl-2 gene, whereas bax level was not affected by E 2 in breast cancer cells (4, 5, 53, 54) . The up-regulation of bcl-2 by E 2 in this series of experiments indirectly suggests that E 2 affects the survival of IOSE-29EC cells through bcl-2, which is known to be a dominant regulator of apoptosis in other tissues (4, 5, 53, 54) . It has been shown that estrogen downregulated proapoptotic bak and antiapoptotic bcl-X L mRNA and protein in a dose-dependent manner, suggesting different members of bcl-2 family may be regulated through different pathway by estrogen (53) . In parallel with the mRNA level, E 2 caused a significant induction of bcl-2 protein level (up to 1.7-fold), whereas no difference was observed in bax mRNA level. This induction of bcl-2 protein by E 2 was attenuated with tamoxifen treatment (10 Ϫ6 m). Thus, the mechanism of estrogen on regulation of apoptotic pathway may be related with up-regulation of bcl-2 gene. Recently, it has been found that the bcl-2 major promoter does not contain cis-acting elements directly involved in transcriptional control by E 2 and that E 2 induces bcl-2 expression via two estrogen-responsive elements located within its coding region (5) .
In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cell lines, which were generated from normal OSE, express both ER␣ and ER␤ at the mRNA and protein levels. E 2 has been demonstrated to prevent tamoxifen induced-apoptosis through ERs. The mechanism of action of E 2 may be associated with upregulation of bcl-2 gene at the mRNA and protein levels. These results suggest that estrogen may play a role in the prevention of apoptosis in tumorigenic OSE cells for ovarian tumorigenesis.
